The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Lung-on-a-chip Market Research Report 2024

Global Lung-on-a-chip Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1896065

No of Pages : 84

Ask Your Query
Synopsis
Lung on a chip. The device is made using human lung and blood vessel cells and it can predict absorption of airborne nanoparticles and mimic the inflammatory response triggered by microbial pathogens. It can be used to test the effects of environmental toxins, absorption of aerosolized therapeutics, and the safety and efficacy of new drugs.
The global Lung-on-a-chip market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Following a strong growth of 26.2 percent in the year 2021, WSTS revised it down to a single digit growth for the worldwide semiconductor market in 2022 with a total size of US$580 billion, up 4.4 percent. WSTS lowered growth estimation as inflation rises and end markets seeing weaker demand, especially those exposed to consumer spending. While some major categories are still double-digit year-over-year growth in 2022, led by Analog with 20.8 percent, Sensors with 16.3 percent, and Logic with 14.5 percent growth. Memory declined with 12.6 percent year over year. In 2022, all geographical regions showed double-digit growth except Asia Pacific. The largest region, Asia Pacific, declined 2.0 percent. Sales in the Americas were US$142.1 billion, up 17.0% year-on-year, sales in Europe were US$53.8 billion, up 12.6% year-on-year, and sales in Japan were US$48.1 billion, up 10.0% year-on-year. However, sales in the largest Asia-Pacific region were US$336.2 billion, down 2.0% year-on-year.
This report aims to provide a comprehensive presentation of the global market for Lung-on-a-chip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung-on-a-chip.
Report Scope
The Lung-on-a-chip market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lung-on-a-chip market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung-on-a-chip companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.
Segment by Type
Pulmonary Inflammation
Pulmonary Infection
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung-on-a-chip companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung-on-a-chip Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pulmonary Inflammation
1.2.3 Pulmonary Infection
1.3 Market by Application
1.3.1 Global Lung-on-a-chip Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung-on-a-chip Market Perspective (2019-2030)
2.2 Lung-on-a-chip Growth Trends by Region
2.2.1 Global Lung-on-a-chip Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Lung-on-a-chip Historic Market Size by Region (2019-2024)
2.2.3 Lung-on-a-chip Forecasted Market Size by Region (2025-2030)
2.3 Lung-on-a-chip Market Dynamics
2.3.1 Lung-on-a-chip Industry Trends
2.3.2 Lung-on-a-chip Market Drivers
2.3.3 Lung-on-a-chip Market Challenges
2.3.4 Lung-on-a-chip Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung-on-a-chip Players by Revenue
3.1.1 Global Top Lung-on-a-chip Players by Revenue (2019-2024)
3.1.2 Global Lung-on-a-chip Revenue Market Share by Players (2019-2024)
3.2 Global Lung-on-a-chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung-on-a-chip Revenue
3.4 Global Lung-on-a-chip Market Concentration Ratio
3.4.1 Global Lung-on-a-chip Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung-on-a-chip Revenue in 2023
3.5 Lung-on-a-chip Key Players Head office and Area Served
3.6 Key Players Lung-on-a-chip Product Solution and Service
3.7 Date of Enter into Lung-on-a-chip Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung-on-a-chip Breakdown Data by Type
4.1 Global Lung-on-a-chip Historic Market Size by Type (2019-2024)
4.2 Global Lung-on-a-chip Forecasted Market Size by Type (2025-2030)
5 Lung-on-a-chip Breakdown Data by Application
5.1 Global Lung-on-a-chip Historic Market Size by Application (2019-2024)
5.2 Global Lung-on-a-chip Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Lung-on-a-chip Market Size (2019-2030)
6.2 North America Lung-on-a-chip Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Lung-on-a-chip Market Size by Country (2019-2024)
6.4 North America Lung-on-a-chip Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung-on-a-chip Market Size (2019-2030)
7.2 Europe Lung-on-a-chip Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Lung-on-a-chip Market Size by Country (2019-2024)
7.4 Europe Lung-on-a-chip Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung-on-a-chip Market Size (2019-2030)
8.2 Asia-Pacific Lung-on-a-chip Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Lung-on-a-chip Market Size by Region (2019-2024)
8.4 Asia-Pacific Lung-on-a-chip Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung-on-a-chip Market Size (2019-2030)
9.2 Latin America Lung-on-a-chip Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Lung-on-a-chip Market Size by Country (2019-2024)
9.4 Latin America Lung-on-a-chip Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung-on-a-chip Market Size (2019-2030)
10.2 Middle East & Africa Lung-on-a-chip Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Lung-on-a-chip Market Size by Country (2019-2024)
10.4 Middle East & Africa Lung-on-a-chip Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Detail
11.1.2 Emulate Business Overview
11.1.3 Emulate Lung-on-a-chip Introduction
11.1.4 Emulate Revenue in Lung-on-a-chip Business (2019-2024)
11.1.5 Emulate Recent Development
11.2 Tissuse
11.2.1 Tissuse Company Detail
11.2.2 Tissuse Business Overview
11.2.3 Tissuse Lung-on-a-chip Introduction
11.2.4 Tissuse Revenue in Lung-on-a-chip Business (2019-2024)
11.2.5 Tissuse Recent Development
11.3 Hesperos
11.3.1 Hesperos Company Detail
11.3.2 Hesperos Business Overview
11.3.3 Hesperos Lung-on-a-chip Introduction
11.3.4 Hesperos Revenue in Lung-on-a-chip Business (2019-2024)
11.3.5 Hesperos Recent Development
11.4 CN Bio Innovations
11.4.1 CN Bio Innovations Company Detail
11.4.2 CN Bio Innovations Business Overview
11.4.3 CN Bio Innovations Lung-on-a-chip Introduction
11.4.4 CN Bio Innovations Revenue in Lung-on-a-chip Business (2019-2024)
11.4.5 CN Bio Innovations Recent Development
11.5 Draper Laboratory
11.5.1 Draper Laboratory Company Detail
11.5.2 Draper Laboratory Business Overview
11.5.3 Draper Laboratory Lung-on-a-chip Introduction
11.5.4 Draper Laboratory Revenue in Lung-on-a-chip Business (2019-2024)
11.5.5 Draper Laboratory Recent Development
11.6 Mimetas
11.6.1 Mimetas Company Detail
11.6.2 Mimetas Business Overview
11.6.3 Mimetas Lung-on-a-chip Introduction
11.6.4 Mimetas Revenue in Lung-on-a-chip Business (2019-2024)
11.6.5 Mimetas Recent Development
11.7 Nortis
11.7.1 Nortis Company Detail
11.7.2 Nortis Business Overview
11.7.3 Nortis Lung-on-a-chip Introduction
11.7.4 Nortis Revenue in Lung-on-a-chip Business (2019-2024)
11.7.5 Nortis Recent Development
11.8 Kirkstall
11.8.1 Kirkstall Company Detail
11.8.2 Kirkstall Business Overview
11.8.3 Kirkstall Lung-on-a-chip Introduction
11.8.4 Kirkstall Revenue in Lung-on-a-chip Business (2019-2024)
11.8.5 Kirkstall Recent Development
11.9 Cherry Biotech SAS
11.9.1 Cherry Biotech SAS Company Detail
11.9.2 Cherry Biotech SAS Business Overview
11.9.3 Cherry Biotech SAS Lung-on-a-chip Introduction
11.9.4 Cherry Biotech SAS Revenue in Lung-on-a-chip Business (2019-2024)
11.9.5 Cherry Biotech SAS Recent Development
11.10 Else Else Kooi Laboratory
11.10.1 Else Else Kooi Laboratory Company Detail
11.10.2 Else Else Kooi Laboratory Business Overview
11.10.3 Else Else Kooi Laboratory Lung-on-a-chip Introduction
11.10.4 Else Else Kooi Laboratory Revenue in Lung-on-a-chip Business (2019-2024)
11.10.5 Else Else Kooi Laboratory Recent Development
11.11 Micronit Microtechnologies B.V.
11.11.1 Micronit Microtechnologies B.V. Company Detail
11.11.2 Micronit Microtechnologies B.V. Business Overview
11.11.3 Micronit Microtechnologies B.V. Lung-on-a-chip Introduction
11.11.4 Micronit Microtechnologies B.V. Revenue in Lung-on-a-chip Business (2019-2024)
11.11.5 Micronit Microtechnologies B.V. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock